Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on August 23, 2023. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily addresses a Regulation FD disclosure regarding a new business initiative.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of a corporate event rather than a financial statement.
Material Changes
The material change disclosed is the announcement of a new subscription model for the Company's PURE EP™ Platform. This represents a strategic shift in the commercialization approach for this specific product line.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release (Exhibit 99.1) detailing the subscription model but explicitly undertakes no obligation to update, supplement, or amend the materials.
- Legal Disclaimer: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Materiality Determination: The Company states that furnishing this information is not intended to constitute a determination that the information is material or that dissemination is required by Regulation FD.
Investor Verification Checklist
- Verify the specific terms and pricing of the new PURE EP™ Platform subscription model in the attached press release (Exhibit 99.1).
- Confirm the impact of this subscription model on future revenue recognition and recurring revenue streams.
- Review the Company's latest 10-Q or 10-K for actual financial performance metrics, as this 8-K contains no financial data.
- Monitor subsequent filings for any updates or amendments regarding the subscription model, noting the Company's explicit disclaimer against updating this specific disclosure.